Closed loop insulin delivery–Opportunities and limitations

Fully automated closed-loop insulin delivery in adults with type 2 diabetes: an open-label, single-center, randomized crossover trial

(2023) Aideen B. Daly et al.   NATURE MEDICINE

First Use of Open-Source Automated Insulin Delivery AndroidAPS in Full Closed-Loop Scenario: Pancreas4ALL Randomized Pilot Study

(2023) Lenka Petruzelkova et al.   Diabetes Technology & Therapeutics

A Deep Learning Framework for Automatic Meal Detection and Estimation in Artificial Pancreas Systems

(2022) John Daniels et al.   SENSORS

Comparison of MiniMed 780G system performance in users aged younger and older than 15 years: Evidence from 12 870 real‐world users

(2022) Arcelia Arrieta et al.   DIABETES OBESITY & METABOLISM

Cambridge Hybrid Closed-Loop System in Very Young Children With Type 1 Diabetes Reduces Caregivers’ Fear of Hypoglycemia and Improves Their Well-Being

(2022) Carine de Beaufort et al.   DIABETES CARE

Open-Source Automated Insulin Delivery in Type 1 Diabetes

(2022) Mercedes J. Burnside et al.   NEW ENGLAND JOURNAL OF MEDICINE

Advanced hybrid closed loop therapy versus conventional treatment in adults with type 1 diabetes (ADAPT): a randomised controlled study

(2022) Pratik Choudhary et al.   Lancet Diabetes & Endocrinology

One Year Real-World Use of the Control-IQ Advanced Hybrid Closed-Loop Technology

(2021) Marc D. Breton et al.   Diabetes Technology & Therapeutics

Multicenter Trial of a Tubeless, On-Body Automated Insulin Delivery System With Customizable Glycemic Targets in Pediatric and Adult Participants With Type 1 Diabetes

(2021) Sue A. Brown et al.   DIABETES CARE

Ultra Rapid Lispro Demonstrates Similar Time in Target Range to Lispro With a Hybrid Closed-Loop System

(2021) Bruce W Bode et al.   Diabetes Technology & Therapeutics

Real-world Performance of the MiniMed™ 780G System: First Report of Outcomes from 4’120 Users

(2021) Julien Da Silva et al.   Diabetes Technology & Therapeutics

Why #WeAreNotWaiting—Motivations and Self-Reported Outcomes Among Users of Open-source Automated Insulin Delivery Systems: Multinational Survey

(2021) Katarina Braune et al.   JOURNAL OF MEDICAL INTERNET RESEARCH

The continuing quest for better subcutaneously administered prandial insulins: a review of recent developments and potential clinical implications

(2020) David R. Owens et al.   DIABETES OBESITY & METABOLISM

State of Type 1 Diabetes Management and Outcomes from the T1D Exchange in 2016–2018

(2019) Nicole C. Foster et al.   Diabetes Technology & Therapeutics

Six-Month Randomized, Multicenter Trial of Closed-Loop Control in Type 1 Diabetes

(2019) Sue A. Brown et al.   NEW ENGLAND JOURNAL OF MEDICINE

Do-It-Yourself Artificial Pancreas System and the OpenAPS Movement

(2019) Dana M. Lewis   ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA

Insulin Injection Into Lipohypertrophic Tissue: Blunted and More Variable Insulin Absorption and Action and Impaired Postprandial Glucose Control

(2016) Susanne Famulla et al.   DIABETES CARE

Effect of a local heating device on insulin and glucose pharmacokinetic profiles in an open-label, randomized, two-period, one-way crossover study in patients with type 1 diabetes using continuous subcutaneous insulin infusion

(2009) Itamar Raz et al.   CLINICAL THERAPEUTICS